SEMA4D and neoplasm: Another potential therapeutic target that may affect MDSCs is semaphorin 4D (Sema4D), a cytokine expressed by several epithelial malignancies and known to induce tumor angiogenesis produced by MDSC resulting in suppression of T-cell proliferation and IFN-γ production (424).